Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Longevity
Biotech
GLP-1 enthusiasm pushes BioAge into new age with $170M series D
BioAge's $170 million series D pushes the company's cash runway into at least late 2026.
Max Bayer
Feb 13, 2024 8:00am
AgeX keeps defying time to survive multiyear cash crunch
Aug 15, 2023 7:00am
Life Bio gene therapy restores visual function in primates
Apr 25, 2023 10:38am
Despite blockbuster Altos funds, longevity investment falls $1B
Jan 31, 2023 11:28am
Korify rolls out $100M longevity and mental health venture fund
Dec 22, 2021 4:20am
Anti-aging foundation SENS parts ways with de Grey
Aug 23, 2021 10:05am